Published in PLoS One on August 16, 2010
High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One (2012) 2.17
Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nat Immunol (2012) 1.99
Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut (2012) 1.99
Interactions between the intestinal microbiome and liver diseases. Gastroenterology (2014) 1.92
Intestinal alkaline phosphatase prevents metabolic syndrome in mice. Proc Natl Acad Sci U S A (2013) 1.89
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J (2012) 1.88
Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) (2011) 1.73
Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol (2012) 1.70
The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol (2013) 1.59
Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One (2012) 1.59
Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J (2012) 1.54
Diet-microbiota interactions as moderators of human metabolism. Nature (2016) 1.31
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol (2011) 1.30
Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling. Cell Metab (2015) 1.22
Dietary Polyphenols Promote Growth of the Gut Bacterium Akkermansia muciniphila and Attenuate High-Fat Diet-Induced Metabolic Syndrome. Diabetes (2015) 1.19
Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care (2011) 1.19
Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18
Gut microbiota, epithelial function and derangements in obesity. J Physiol (2011) 1.17
Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact (2011) 1.16
An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy. PLoS One (2014) 1.15
Gut microbiota and metabolic syndrome. World J Gastroenterol (2014) 1.14
Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin. Physiol Behav (2011) 1.13
Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci (2014) 1.08
Themes in fibrosis and gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol (2011) 1.03
Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium. Obes Rev (2011) 1.02
High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity. PLoS One (2013) 1.00
Transfer of gut microbiota from lean and obese mice to antibiotic-treated mice. Sci Rep (2014) 0.99
Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes (2013) 0.97
Obesity surgery and gut-brain communication. Physiol Behav (2011) 0.97
Impacts of gut bacteria on human health and diseases. Int J Mol Sci (2015) 0.97
Targeting xenobiotic receptors PXR and CAR for metabolic diseases. Trends Pharmacol Sci (2012) 0.97
Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol (2015) 0.97
Microbiota-induced obesity requires farnesoid X receptor. Gut (2016) 0.96
The gut microbiota and liver disease. Cell Mol Gastroenterol Hepatol (2015) 0.93
T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding. PLoS One (2010) 0.93
High fat diet attenuates glucose-dependent facilitation of 5-HT3 -mediated responses in rat gastric vagal afferents. J Physiol (2015) 0.93
High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes. Cell Tissue Res (2013) 0.92
Properties of myenteric neurones and mucosal functions in the distal colon of diet-induced obese mice. J Physiol (2013) 0.92
Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clin Biochem (2015) 0.91
Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflamm (2014) 0.91
Gut Microbiota: Modulation of Host Physiology in Obesity. Physiology (Bethesda) (2016) 0.90
Impact of diet-induced obesity on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires insulin/IGF1. Endocrinology (2014) 0.90
Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response. J Nutr Biochem (2012) 0.90
The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What Should be the Ideal Treatment? Clin Transl Gastroenterol (2013) 0.90
Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr (2013) 0.89
Diet-induced regulation of bitter taste receptor subtypes in the mouse gastrointestinal tract. PLoS One (2014) 0.89
Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Front Immunol (2014) 0.88
The role of fatty acids in insulin resistance. Lipids Health Dis (2015) 0.88
Activation of rat intestinal mucosal mast cells by fat absorption. Am J Physiol Gastrointest Liver Physiol (2012) 0.87
Table grape consumption reduces adiposity and markers of hepatic lipogenesis and alters gut microbiota in butter fat-fed mice. J Nutr Biochem (2015) 0.87
Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids. Drug Metab Dispos (2015) 0.86
Diet-induced obesity promotes colon tumor development in azoxymethane-treated mice. PLoS One (2013) 0.85
High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One (2015) 0.85
Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. J Lipid Res (2016) 0.84
Elevated IgG levels against specific bacterial antigens in obese patients with diabetes and in mice with diet-induced obesity and glucose intolerance. Metabolism (2012) 0.84
Role of TNFR1 in the innate airway hyperresponsiveness of obese mice. J Appl Physiol (1985) (2012) 0.84
High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22. Sci Rep (2016) 0.84
Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice. PLoS One (2015) 0.84
Hepatic function and the cardiometabolic syndrome. Diabetes Metab Syndr Obes (2013) 0.83
Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity. Diabetes Metab Syndr Obes (2012) 0.83
Attenuation of tick-borne encephalitis virus using large-scale random codon re-encoding. PLoS Pathog (2015) 0.83
Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. Int J Neuropsychopharmacol (2016) 0.82
Disparate Metabolic Responses in Mice Fed a High-Fat Diet Supplemented with Maize-Derived Non-Digestible Feruloylated Oligo- and Polysaccharides Are Linked to Changes in the Gut Microbiota. PLoS One (2016) 0.82
Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation. Nat Commun (2014) 0.82
Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells. EBioMedicine (2017) 0.82
Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes. Gut Microbes (2016) 0.82
Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature. J Obes (2016) 0.81
Inflammatory Signaling Involved in High-Fat Diet Induced Prostate Diseases. J Urol Res (2015) 0.81
High-fat diet and age-dependent effects on enteric glial cell populations of mouse small intestine. Auton Neurosci (2013) 0.81
Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk. Curr Opin Clin Nutr Metab Care (2015) 0.80
GSK3β is increased in adipose tissue and skeletal muscle from women with gestational diabetes where it regulates the inflammatory response. PLoS One (2014) 0.80
The Gut Microbiota of Wild Mice. PLoS One (2015) 0.80
Electrophysiological analysis of the mechanism of autonomic action by lactobacilli. Biosci Microflora (2011) 0.80
Uncovering the composition of microbial community structure and metagenomics among three gut locations in pigs with distinct fatness. Sci Rep (2016) 0.80
Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD. J Lipid Res (2016) 0.80
Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome. J Biol Chem (2015) 0.79
Gut-central nervous system axis is a target for nutritional therapies. Nutr J (2012) 0.79
Holobiont nutrition: considering the role of the gastrointestinal microbiota in the health benefits of whole grains. Gut Microbes (2013) 0.79
Gut Microbiome and Obesity: A Plausible Explanation for Obesity. Curr Obes Rep (2015) 0.79
The Effect of Diet and Exercise on Intestinal Integrity and Microbial Diversity in Mice. PLoS One (2016) 0.79
Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats. PLoS One (2016) 0.79
Intestinal alkaline phosphatase: a summary of its role in clinical disease. J Surg Res (2015) 0.79
Overexpression of gastric leptin precedes adipocyte leptin during high-fat diet and is linked to 5HT-containing enterochromaffin cells. Int J Obes (Lond) (2014) 0.78
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int J Mol Sci (2016) 0.78
Jussara (Euterpe edulis Mart.) supplementation during pregnancy and lactation modulates the gene and protein expression of inflammation biomarkers induced by trans-fatty acids in the colon of offspring. Mediators Inflamm (2014) 0.78
Stool phospholipid signature is altered by diet and tumors. PLoS One (2014) 0.78
Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAs. Am J Physiol Gastrointest Liver Physiol (2014) 0.78
Bacterial metabolites directly modulate farnesoid X receptor activity. Nutr Metab (Lond) (2015) 0.78
Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon. Am J Physiol Gastrointest Liver Physiol (2015) 0.77
TNF-alpha and IL-6 inhibit apolipoprotein A-IV production induced by linoleic acid in human intestinal Caco2 cells. J Inflamm (Lond) (2015) 0.77
Morphoquantitative analysis of the Ileum of C57BL/6 mice (Mus musculus) fed with a high-fat diet. Int J Clin Exp Pathol (2015) 0.77
The role of beneficial bacteria wall elasticity in regulating innate immune response. EPMA J (2015) 0.77
Nonlinear transcriptomic response to dietary fat intake in the small intestine of C57BL/6J mice. BMC Genomics (2016) 0.77
Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World J Hepatol (2015) 0.77
Bardoxolone Methyl Prevents High-Fat Diet-Induced Colon Inflammation in Mice. J Histochem Cytochem (2016) 0.77
High dietary lipid level is associated with persistent hyperglycaemia and downregulation of muscle Akt-mTOR pathway in Senegalese sole (Solea senegalensis). PLoS One (2014) 0.77
The oral microflora in obesity and type-2 diabetes. J Oral Microbiol (2012) 0.77
Utilisation of ISA Reverse Genetics and Large-Scale Random Codon Re-Encoding to Produce Attenuated Strains of Tick-Borne Encephalitis Virus within Days. PLoS One (2016) 0.77
The obese gut microbiome across the epidemiologic transition. Emerg Themes Epidemiol (2016) 0.77
Heritable components of the human fecal microbiome are associated with visceral fat. Genome Biol (2016) 0.77
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 41.22
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 32.01
The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 26.56
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med (1997) 14.51
Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 14.12
IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 12.07
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature (1997) 10.53
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A (2007) 9.71
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 6.50
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab (2001) 5.76
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem (2001) 5.12
High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology (2009) 5.08
Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr (2006) 4.72
Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab (2000) 3.42
Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med (2004) 2.82
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A (2004) 2.54
The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis (2005) 2.18
Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab (1998) 2.12
ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice. Am J Physiol Cell Physiol (2006) 2.02
Low-grade systemic inflammation in overweight children. Pediatrics (2001) 1.99
Retracted Deletion of tumor necrosis factor-alpha receptor 1 (TNFR1) protects against diet-induced obesity by means of increased thermogenesis. J Biol Chem (2009) 1.88
In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol (2004) 1.84
Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab (2007) 1.49
Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) (2008) 1.47
Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes. Diabetes (2007) 1.42
Adipose tissue and adipokines--energy regulation from the human perspective. J Nutr (2006) 1.37
Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab (2009) 1.29
Receptors for tumor necrosis factor-alpha play a protective role against obesity and alter adipose tissue macrophage status. Endocrinology (2009) 1.13
Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents. Neuro Endocrinol Lett (2006) 0.99
Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 7.54
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med (2010) 4.37
Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology (2003) 3.51
Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science (2010) 2.99
The microbiome and cancer. Nat Rev Cancer (2013) 2.86
Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One (2009) 2.79
NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity (2012) 2.07
Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci (2002) 1.95
In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol (2004) 1.84
Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol (2007) 1.82
Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis. J Immunol (2008) 1.68
Activation of two distinct Sox9-EGFP-expressing intestinal stem cell populations during crypt regeneration after irradiation. Am J Physiol Gastrointest Liver Physiol (2012) 1.67
STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood (2004) 1.58
Identification of a new glycerol-3-phosphate acyltransferase isoenzyme, mtGPAT2, in mitochondria. J Biol Chem (2004) 1.55
Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm Bowel Dis (2007) 1.55
IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem (2002) 1.48
Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2. J Biol Chem (2005) 1.41
Microbial colonization induces dynamic temporal and spatial patterns of NF-κB activation in the zebrafish digestive tract. Gastroenterology (2011) 1.39
NF-kappaB and the intestine: friend or foe? Inflamm Bowel Dis (2008) 1.33
Think small: zebrafish as a model system of human pathology. J Biomed Biotechnol (2012) 1.30
Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J Immunol (2007) 1.22
Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model. ISME J (2013) 1.21
Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care (2011) 1.19
Mouse background strain profoundly influences Paneth cell function and intestinal microbial composition. PLoS One (2012) 1.19
Cloning and functional characterization of a novel mitochondrial N-ethylmaleimide-sensitive glycerol-3-phosphate acyltransferase (GPAT2). Arch Biochem Biophys (2007) 1.19
Effects of aging on the hippocampal formation in a naturally occurring animal model of mild cognitive impairment. Exp Gerontol (2003) 1.18
Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm Bowel Dis (2011) 1.16
The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis (2011) 1.15
Tumor necrosis factor and interferon-gamma down-regulate Klotho in mice with colitis. Gastroenterology (2009) 1.15
Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett (2011) 1.12
Interaction between resident luminal bacteria and the host: can a healthy relationship turn sour? J Pediatr Gastroenterol Nutr (2004) 1.10
The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology (2005) 1.10
L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS One (2012) 1.08
Tomato lycopene extract prevents lipopolysaccharide-induced NF-kappaB signaling but worsens dextran sulfate sodium-induced colitis in NF-kappaBEGFP mice. PLoS One (2009) 1.07
Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One (2012) 1.06
Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur J Immunol (2005) 1.06
Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer. Mol Pharmacol (2008) 1.06
Impaired Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice. J Biol Chem (2008) 1.04
Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells. Oncogene (2005) 1.04
Oxymatrine prevents NF-κB nuclear translocation and ameliorates acute intestinal inflammation. Sci Rep (2013) 1.02
Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells. J Cell Physiol (2004) 1.02
Gnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylobacter jejuni infection. PLoS One (2009) 1.02
Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA. Infect Immun (2007) 1.01
Selective loss of vagal intramuscular mechanoreceptors in mice mutant for steel factor, the c-Kit receptor ligand. Anat Embryol (Berl) (2002) 1.01
Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol (2005) 1.00
Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9. Endocrinology (2007) 0.99
Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta. J Clin Invest (2013) 0.99
Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling. Gastroenterology (2011) 0.98
The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes (2013) 0.98
Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda. Inflamm Bowel Dis (2013) 0.97
The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction. Immunity (2012) 0.97
Mu opioid signaling protects against acute murine intestinal injury in a manner involving Stat3 signaling. Am J Pathol (2011) 0.96
PI3K-dependent GSK3ß(Ser9)-phosphorylation is implicated in the intestinal epithelial cell wound-healing response. PLoS One (2011) 0.96
Intestinal epithelial-derived TAK1 signaling is essential for cytoprotection against chemical-induced colitis. PLoS One (2009) 0.95
Commensal microbiota stimulate systemic neutrophil migration through induction of serum amyloid A. Cell Microbiol (2014) 0.95
Intestinal epithelial cell-derived μ-opioid signaling protects against ischemia reperfusion injury through PI3K signaling. Am J Pathol (2013) 0.94
Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer. Am J Physiol Gastrointest Liver Physiol (2011) 0.93
The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells. Shock (2011) 0.93
The gastrointestinal tract "tastes" nutrients: evidence from the intestinal taste aversion paradigm. Am J Physiol Regul Integr Comp Physiol (2004) 0.92
A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis. PLoS One (2012) 0.92
Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes. J Cell Physiol (2006) 0.91
NF-kappaB-inducing kinase restores defective IkappaB kinase activity and NF-kappaB signaling in intestinal epithelial cells. Cell Signal (2004) 0.91
Glafenine-induced intestinal injury in zebrafish is ameliorated by μ-opioid signaling via enhancement of Atf6-dependent cellular stress responses. Dis Model Mech (2012) 0.91
Diet, microbiome, and the intestinal epithelium: an essential triumvirate? Biomed Res Int (2013) 0.91
The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB(EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules. PLoS One (2007) 0.89
Cationic amino acid transporter 2 enhances innate immunity during Helicobacter pylori infection. PLoS One (2011) 0.89
Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas. BMC Cancer (2008) 0.89
Adenosine is a negative regulator of NF-kappaB and MAPK signaling in human intestinal epithelial cells. Cell Immunol (2005) 0.88
Mitochondrial DNA polymerase editing mutation, PolgD257A, disturbs stem-progenitor cell cycling in the small intestine and restricts excess fat absorption. Am J Physiol Gastrointest Liver Physiol (2012) 0.88
Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish. Inflamm Bowel Dis (2014) 0.88
VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep (2013) 0.87
Disruption of nitric oxide signaling by Helicobacter pylori results in enhanced inflammation by inhibition of heme oxygenase-1. J Immunol (2011) 0.87
Colorectal cancer: CRC--all about microbial products and barrier function? Nat Rev Gastroenterol Hepatol (2012) 0.87
Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo. Am J Physiol Gastrointest Liver Physiol (2006) 0.86
Gastrointestinal tract innervation of the mouse: afferent regeneration and meal patterning after vagotomy. Am J Physiol Regul Integr Comp Physiol (2005) 0.86
Fate of goblet cells in experimental colitis. Dig Dis Sci (2002) 0.85
Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Invest Ophthalmol Vis Sci (2012) 0.85
Phosphatidylinositol 3-kinase-γ signaling promotes Campylobacter jejuni-induced colitis through neutrophil recruitment in mice. J Immunol (2012) 0.83
Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation. Am J Pathol (2010) 0.82
Obesity: should treatments target visceral afferents? Physiol Behav (2005) 0.82
Differential requirement for NF-kappaB-inducing kinase in the induction of NF-kappaB by IL-1beta, TNF-alpha, and Fas. Am J Physiol Cell Physiol (2002) 0.82
Regulation and functional impact of lipopolysaccharide induced Nod2 gene expression in the murine epididymal epithelial cell line PC1. Immunology (2008) 0.82
Chemotherapy, immunity and microbiota--a new triumvirate? Nat Med (2014) 0.82
Deletion of cationic amino acid transporter 2 exacerbates dextran sulfate sodium colitis and leads to an IL-17-predominant T cell response. Am J Physiol Gastrointest Liver Physiol (2013) 0.81
Structural identification of mouse fecal metabolites of theaflavin 3,3'-digallate using liquid chromatography tandem mass spectrometry. J Chromatogr A (2011) 0.79
Intestinal epithelial cells and innate immunity in the intestine: is CARD15/Nod2 another player? Gastroenterology (2003) 0.79
The microbiota is essential for the generation of black tea theaflavins-derived metabolites. PLoS One (2012) 0.79
MyD88 signaling in the intestine: Dr Jekyll and Mr Hyde? Gastroenterology (2010) 0.78
Role of NF-kappaB in inflammatory disorders: just when you thought you knew everything! J Pediatr Gastroenterol Nutr (2004) 0.78
Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models. Inflamm Bowel Dis (2014) 0.78
The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention. Inflamm Bowel Dis (2015) 0.78
Epithelial cell-specific MyD88 signaling mediates ischemia/reperfusion-induced intestinal injury independent of microbial status. Inflamm Bowel Dis (2013) 0.78
Time dependency and topography of hepatic nuclear factor κB activation after hemorrhagic shock and resuscitation in mice. Shock (2012) 0.77
From promotion to management: the wide impact of bacteria on cancer and its treatment. Bioessays (2014) 0.76
Ubiquitin protein modification and signal transduction: implications for inflammatory bowel diseases. Inflamm Bowel Dis (2005) 0.76
[Microbial dysbiosis, a new risk factor in colorectal cancer?]. Med Sci (Paris) (2013) 0.76
Gut Microbiota and a Selectively Bred Taste Phenotype: A Novel Model of Microbiome-Behavior Relationships. Psychosom Med (2016) 0.76
Microbiota in chronic mucosal inflammation. Int J Inflam (2011) 0.75
NSAID-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells. ACS Infect Dis (2017) 0.75